Accession Number: | 0000898432-20-000675 |
Date: | 2020-07-24 |
Issuer: | IRADIMED CORP (IRMD) |
Original Submission Date: |
WALDMAN LOUIS S.
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-24 | M | 5,155 | a | $0.00 | 40,155 | direct | ||
COMMON STOCK | 2020-07-24 | F | 1,254 | d | $23.47 | 38,901 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-07-24 | deemed execution date | M | 750 (d) | common stock 750 | $0.00 | 0 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-07-24 | deemed execution date | M | 1,476 (d) | common stock 1,476 | $0.00 | 0 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-07-24 | deemed execution date | M | 1,181 (d) | common stock 1,181 | $0.00 | 0 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-07-24 | deemed execution date | M | 1,748 (d) | common stock 1,748 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | as previously disclosed, the reporting person received restricted stock units under the issuer's 2014 equity incentive plan on december 14, 2016, december 4, 2017, december 7, 2018, and december 7, 2019. pursuant to the reporting person's separation agreement with the issuer (the "separation agreement"), upon his separation from the issuer on july 24, 2020 (the "retirement date"), all of his unvested restricted stock units, amounting to 5,155 shares of common stock, accelerated and vested as of the retirement date as follows: (i) 750 unvested restricted stock units accelerated and vested from the december 14, 2016 grant; (ii) 1,476 unvested restricted stock units accelerated and vested from the december 4, 2017 grant; (iii) 1,181 unvested restricted stock units accelerated and vested from the december 7, 2018 grant; and (iv) 1,748 unvested restricted stock units accelerated and vested from the december 7, 2019 grant (collectively, the "rsus"). |
f2 | shares surrendered to the issuer for payment of tax liability incident to the accelerated vesting of a total of 5,155 restricted stock units. |
f3 | each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
f4 | all of the unvested rsus were accelerated on the retirement date pursuant to the terms of the separation agreement. |